iTAP, a novel iRhom interactor, controls TNF secretion by policing the stability of iRhom/TACE

Ioanna Oikonomidi,Emma Burbridge,Miguel Cavadas,Graeme Sullivan,Danielle Clancy,Blanka Collis,Jana Brezinova,Jana Humpolickova,Tianyi Hu,Andrea Bileck,Christopher Gerner,Alfonso Bolado,Alex von Kriegsheim,Kvido Strisovsky,Seamus J. Martin,Colin Adrain
DOI: https://doi.org/10.1101/255745
2018-01-30
Abstract:Abstract The apical inflammatory cytokine TNF regulates numerous important biological processes including inflammation and cell death, and drives inflammatory diseases. TNF secretion requires ADAM17/TACE, which cleaves TNF from its transmembrane tether, releasing it for signalling. The trafficking of ADAM17/TACE to the cell surface, and stimulation of its proteolytic activity, depends on membrane proteins, called iRhoms. To delineate how the TNF/TACE/iRhom axis is regulated, we performed an immunoprecipitation/mass spectrometry screen to identify iRhom-binding proteins. Here we report a novel protein, that we name iTAP (iRhom tail- a ssociated p rotein) that binds to iRhoms, enhancing the stability of iRhoms and TACE, preventing their degradation in lysosomes. iTAP-null primary human macrophages, or tissues from iTAP KO mice, are dramatically depleted in the levels of iRhom2 and active TACE, and are, consequently, profoundly impaired in TNF production. Our work illustrates iTAP as a physiological rheostat controlling TNF signalling and a novel target for the control of inflammation.
What problem does this paper attempt to address?